ArticleCellular and molecular neurobiology2025
A Technical Assessment of a Commercial GFAP Lateral Flow Assay to Establish Proof-of-Concept for Use in Traumatic Brain Injury.
Daniel P Whitehouse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.